S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
Log in

CVE:PBS - Pacgen Life Science Stock Price, Forecast & News

Today's Range N/A
50-Day Range
C$0.02
MA: C$0.02
C$0.03
52-Week Range N/A
Volume10,000 shs
Average Volume34,993 shs
Market CapitalizationC$1.30 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Pacgen Life Science Corporation, a life sciences company, focuses on building a commercial platform to market and distribute consumer health products in North America. It markets its oral and skin care products under the P113+, DermaMed, DermaSoleil, and Deserving Health brand names. The company was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in May 2012. Pacgen Life Science Corporation was founded in 2004 and is headquartered in Vancouver, Canada.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-4364388

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$444,154.00
Book ValueC$0.00 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$1.30 million
Next Earnings Date3/6/2020 (Estimated)
OptionableNot Optionable

Receive PBS News and Ratings via Email

Sign-up to receive the latest news and ratings for PBS and its competitors with MarketBeat's FREE daily newsletter.


Pacgen Life Science (CVE:PBS) Frequently Asked Questions

What is Pacgen Life Science's stock symbol?

Pacgen Life Science trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PBS."

When is Pacgen Life Science's next earnings date?

Pacgen Life Science is scheduled to release their next quarterly earnings announcement on Friday, March 6th 2020. View Earnings Estimates for Pacgen Life Science.

Has Pacgen Life Science been receiving favorable news coverage?

News coverage about PBS stock has trended extremely negative recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Pacgen Life Science earned a media sentiment score of -4.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Pacgen Life Science.

Who are some of Pacgen Life Science's key competitors?

Who are Pacgen Life Science's key executives?

Pacgen Life Science's management team includes the folowing people:
  • Mr. Chung-Yu Wang B.Sc., Ph.D., EMBA, Co-Founder & Chairman (Age 74)
  • Ms. Christina Yip MBA, BBA (Honours), CPA, CMA, CEO, Pres & Director (Age 55)
  • Mr. Fred Huang BA, MBA, Co-Founder & Director (Age 67)
  • Ms. Andrea Chan, Interim CFO & Corp. Sec.
  • Mr. Ivan Wong, Exec. VP of Operations

How do I buy shares of Pacgen Life Science?

Shares of PBS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How big of a company is Pacgen Life Science?

Pacgen Life Science has a market capitalization of C$0.00 and generates C$444,154.00 in revenue each year. View Additional Information About Pacgen Life Science.

What is Pacgen Life Science's official website?

The official website for Pacgen Life Science is http://www.pacgenlife.com/.

How can I contact Pacgen Life Science?

Pacgen Life Science's mailing address is 666 Burrard St Suite 500, VANCOUVER, BC V6C 3P6, Canada. The company can be reached via phone at +1-604-4364388.


MarketBeat Community Rating for Pacgen Life Science (CVE PBS)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  55 (Vote Outperform)
Underperform Votes:  40 (Vote Underperform)
Total Votes:  95
MarketBeat's community ratings are surveys of what our community members think about Pacgen Life Science and other stocks. Vote "Outperform" if you believe PBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel